Norway· NO-ID_8B9D2FD2-36DE-49B9-AA16-9BF12A06E153
Lithionit
A lithium product containing lithium sulphate + anhydrous, registered in Norway by Karo Pharma AB (1). The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lithium is registered in 15 of 19 countries.
Countries holding a registration under ATC N05AN01 (lithium), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Lithium · ATC N05AN01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Lithium Sulphate + Anhydrous
- Manufacturer
- Karo Pharma AB (1)
- Country
- Norway (NO)
- ATC code
- N05AN01
- ATC class
- Lithium
- Defined daily dose
- 24 mmol, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_8B9D2FD2-36DE-49B9-AA16-9BF12A06E153
- no_varenummer005923100NOK 345.9
- gtin7350094060248
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for lithium.
Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lithium · interactions on record
428 records
- 73 severe
- 250 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
90 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AN01
Lithium, as other registers publish it.
- NorwayApo-Lithium carbonateApotex
- CanadaAPO-LITHIUM CARBONATEAPOTEX INC
- CanadaAPO-LITHIUM CARBONATEAPOTEX INC
- United StatesBestmade Natural Products Lithium Chloride (Lith Mur)Bestmade Natural Products
- United StatesBM Lithium chloride (Lith Mur)BM Private Limited
- BelgiumCamcolit 250 250 mgEssential Pharma (M)
- IrelandCAMCOLIT 250 mg film-coated tabletsEssential Pharma (M) Limited
- United KingdomCamcolit 250 tabletsEssential Pharma Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc286578-5f18-44d4-87b6-aad986fee1ae GET /v1/drugs/cc286578-5f18-44d4-87b6-aad986fee1ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Depottablett",
"source": "fest",
"status": "A",
"atc_name": "Litium",
"merkevare_id": "ID_8B9D2FD2-36DE-49B9-AA16-9BF12A06E153",
"name_form_strength": "Lithionit depottab 42 mg",
"prescription_group": "C"
}See everything about lithium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.